Viewing Study NCT00135369


Ignite Creation Date: 2025-12-24 @ 10:46 PM
Ignite Modification Date: 2026-03-26 @ 8:19 PM
Study NCT ID: NCT00135369
Status: COMPLETED
Last Update Posted: 2011-04-25
First Post: 2005-08-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Switching HIV-1 Infected Subjects From a Highly Active Anti-Retroviral Treatment (HAART) Regimen Dosed Twice Daily or More Frequently to a Once-Daily Regimen
Sponsor: Bristol-Myers Squibb
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module